Health Care Equipment & Services
Global Health (GLH) specialises in software products for the healthcare industry. GLH’s health solutions business (70% earnings) is marketed under the ‘Global Health’ banner. Working Systems Solutions specialises in e-health, e-business, e-learning and application integration. Its products include Locum 3 for patient management, MasterCare, a browser-based data repository providing clinical information on patients, and e-PAS, a financial, patient, and practice management application.
Fermiscan Holdings (FER) is the owner of a patented diagnostic technique entitled "Using Hair to Screen for Breast Cancer". The focus of the company is on the development of the technology called The Fermiscan Test, which discovers a technique of using X-ray diffraction of hair to investigate early potential detection for breast cancer. FER is also exploring other diagnostic technologies with the aim of providing low-cost diagnostics for a range of diseases.
Ellex Medical Lasers (ELX) is involved in the design and manufacture of ophthalmic lasers. ELX manufactures products for Alcon Surgical and Lumenis Inc, as well as distributes under its own brand Laserex. ELX primarily manufactures photodisruptor lasers for the treatment of secondary cataracts and photocoagulator lasers for treating various retinal diseases. ELX was first listed on the ASX as Gemstone Corporation of Australia in 1994. Ellex was founded by Victor Previn as a private company in the late 1980s. In 1988, it introduced the YAG Photocoagulator.
Eastland Medical Systems (EMS) is involved in the development and manufacture of injection, infusion and blood-drawing devices. EMS's products are specifically designed to reduce the risk of needlestick injuries to healthcare workers. Core products include clip on converters, which convert conventional syringes into retractable needles; AutoInjecta, a fillable device for self-administration of drugs; and Safe Line Winged Infusion Set, a flexible IV line that reduces the risk of a needle stick injury.
Isoft Group (ISF) supplies software and IT solutions to healthcare providers such as hospitals, clinics, pharmacists, aged care facilities and GPs. ISF's clients range from private healthcare providers such as Healthscope to public sector bodies such as defence forces and health authorities. The company earns revenue from the initial sale of its products, followed by ongoing maintenance, support and licence revenues. iSOFT Group Limited’s products support both private and public sector healthcare provider organizations. On April 24, 2009, the Company acquired Hatrix Pty Limited.
Cyclopharm Limited (CYC) is engaged in the manufacture and sale of medical equipment and radiopharmaceuticals, including associated research and development. CYC was listed on ASX on 18 January, 2007. The Company operates in two segments: Technegas and Molecular Imaging. The Technegas segment is a supplier of diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism. The Molecular Imaging segment focuses to produce radiopharmaceuticals to be used by physicians in the detection of cancer, neurological disorders and cardiac disease.
Cordlife (CBB) core business is in adult stem cell therapeutics and cell-based products and services. Each of the group operating businesses is currently revenue generating. The company owns a portfolio of patented stem cell expansion technology for supporting cellular transplantations, as well as T-cell production technology for restoring the immune system. These technologies will enter clinical trials in 2006 and will evolve to clinical therapeutic products.
Compumedics (CMP) is a leader in developing and manufacturing diagnostic technology for sleep and associated disorders. CMP was listed on ASX on 21 December, 2000. Its technology focuses on the fast growing sleep medicine market though it is increasingly focusing on the associated fields of neurodiagnostics and brain research. By defining life's signals, CMP's technology turns vast amounts of data into valuable information that leads to more accurate diagnosis and consequently more effective therapy for some of the most serious health conditions.
Clover Corporation Ltd (CLV) develops and markets products from tuna fish oil and other natural oils, for use in the food, pharmaceutical and farming industries. CLV has developed a high grade DHA (Omega-3 fatty acid) for use in children's formula and bread. Hi-DHA is a refined form of tuna fish oil, devoid of smell or taste. The company has also developed a technology to supply Hi-DHA in a dry powder form. CLV is also developing Prosperm a process aimed at incorporating Hi-DHA into animal feed.
CathRx (CXD) is an Australian medical devices company, initially focusing on the development and commercialisation of a range of cardiac catheters for use in the diagnosis and treatment of electrical problems of the heart known as cardiac arrhythmias. The Company is listed on the Australian Securities Exchange where it is traded under the symbol CXD. It's head office, laboratory and manufacturing facilities are based at Homebush Bay in Sydney. The Company prides itself on innovative design and technology to provide catheters with significant advantages for the cardiac clinicians and patients.
- Free Tickets to Trading & Investing Seminar & Expo ($18) Brisbane 2013
- Stock Calc App
- All About Warrants
- Introduction to Exchange Traded Funds
- Introduction to Exchange Traded Funds: Features
- Introduction to Exchange Traded Funds: Domestic ETFs
- Introduction to Exchange Traded Funds: International ETFs
- Exchange Traded Commodities
- Exchange Traded Commodities: In Summary
- How much Should I Pay for an Option?
- Options Trading: Time Value
- Options Pricing
- Why You Should Trade Index Options
- How to Weather out Flat Markets Using Options
- Protect your Shares
- Australian Stock Scan
- Australian Online Share Trading
- List of Trading Books
- Interesting Thoughts about the Australian Dollar
- What's the Meaning of Hawkish?
- Do You Know How To Use the P/E Ratio
- Trading, Religion and Politics - Do They Have Anything in Common?
- Shares that are Volatile that Double and Half in the Short Term
- Telstra (TLS) T3
- Margin Call by E-mail
- The Cost of Holding a Position
- Lack of Disclosure: Compensation from ASX Listed Company
- Unrealistic Returns and Benchmarks
- CMC Markets Down
- Quality versus Quantity Forex Trading
- Woolworths 1H Sales $30.7bn up 3.2%
Date added 31-01-2013
- ASIC Fines CommBank's CommSec
Date added 25-09-2012
- Industry Super Network Calls to Ban High Frequency Trading (HFT)
Date added 22-09-2012
- NAB Launches Online Share Trading Platform
Date added 19-09-2012
- Reserve Bank of Australia Says 23 Countries Holding AUD
Date added 18-09-2012
- Australia Post Digital Mailbox
Date added 10-09-2012
- Winners and Losers of Trading for Week 2
Date added 16-01-2012
- 2012's First Week of the Best and Worst Traded Stocks
Date added 09-01-2012
- 2011's Last Best and Worst Traded Stocks
Date added 05-01-2012
- Best and Worst Pre-Christmas Traded Stocks
Date added 30-12-2011
- Trading Winners and Losers for Dec. 12-16
Date added 19-12-2011
- Best and Worst Traded Stocks for Dec. 5-9
Date added 13-12-2011
- Top 3 Best and Worst Traded Stocks
Date added 05-12-2011
- ASX Glitch Trading Halt
Date added 27-10-2011
- Worst Trade Stocks (and the Best)
Date added 06-08-2011
Top 150 Public Companies Listed on the Australian Stockmarket as at 29/05/2009
- BHP Billiton
- Westpac Banking Corporation (WBC)
- Commonwealth Bank of Australia (CBA)
- National Australia Bank (NAB)
- Telstra (TLS)
- News Corporation (NWS)
- Woolworths Limited(WOW)
- Woodside Petroleum Limited (WPL)
- Rio Tinto
- Westfield Group (WDC)
- Westfarmers Limited (WES)
- QBE Insurance
- Newcrest Mining Limited (NCM)
- Origin Energy Limited (ORG)
- Santos Limited (STO)
- AMP Limited (AMP)
- Macquarie Group (MQG)
- Foster’s Group Limited (FGL)